Skip to main content
Log in

Prevalence of active infection withChlamydia pneumoniae and human cytomegalovirus in patients with type II diabetes mellitus

  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

By promoting the inflammatory process in the arterial wall,Chlamydia pneumoniae (CPN) and human cytomegalovirus (CMV) participate in the pathogenesis of cardiovascular disease (CVD). Since patients with diabetes mellitus (DM) are at high risk of CVD, we studied markers of CMV and CPN infection in DM patients as possible predictors of cardiovascular complications. The seroprevalence rates of CMV in 44 DM patients and matched controls were 74 and 88 %, respectively. Compared with controls, patients showed lower titers of IgG against CMV (p < 0.001) and higher titers of genus-specific IgA against CPN (p = 0.006). The titers of genus-specific IgG and prevalence rates of type-specific anti-CPN IgA, IgG or IgM were similar in both DM patients and controls. Serological markers of either active or recent CPN infection were detected in 54 % of patients and 59 % of controls. However, CPN DNA was not detected in the blood of any DM patient. CMV DNA was found in the blood of 1 (2.3 %) patient. The results do not indicate an increased rate of CMV or CPN infection in patients with type II DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CMV:

cytomegalovirus

CPN:

Chlamydia pneumoniae

CVD:

cardiovascular diseases

DM:

diabetes mellitus

MIF:

microfluorescence

References

  • Altannavch T., Roubalová K., Brož J., Hrubá D., Anděl M.: Serological markers ofChlamydia pneumoniae, cytomegalovirus andHelicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris.Centr.Eur.J.Publ.Health 11, 102–106 (2003).

    Google Scholar 

  • Bas S., Muzzin P., Ninet J., Bornard J.E., Scieux C., Vischer T.L.: Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test and immunoassays using different recombinant proteins as antigens.J.Clin.Microbiol. 39, 1368–1377 (2004).

    Article  Google Scholar 

  • Bulut Y., Faure E., Thomas L., Karahashi H., Michelsen K.S., Equils O., Morrison S.G., Morrison R.P., Arditi M.: Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in MyD88-dependent pathway.J.Immunol. 168, 1435–1440 (2002).

    PubMed  CAS  Google Scholar 

  • Dandona P., Ajada A., Bandyopadhyay A.: Inflammation: the link between insulin resistance, obesity and diabetes.Trends Immunol. 25, 4–7 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Danesh J., Collins R., Peto R.: Chronic infections and coronary heart disease: is there a link?Lancet 350, 430–436 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Dowell S.F., Peeling R.W., Boman J., Carlone G.M., Fields B.S., Guarner J., Hammerschlag M.R., Jackson L.A., Kuo C.C., Maass M., Messmer T., Talkington D.F., Tondella M.L., Zaki S.R.: StandardizingChlamydia pneumoniae assays: recommendations from the centers for disease control and prevention (USA) and laboratory centre for disease control (Canada).Clin.Infect.Dis. 33, 492–503 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Greelings S., Hoepelman A.: Immune dysfunction in patients with diabetes mellitus (DM).FEMS Immunol.Med.Microbiol. 26, 259–265 (1999).

    Article  Google Scholar 

  • High K.P.: Atherosclerosis and infection due toChlamydia pneumoniae or cytomegalovirus: weighing the evidence.Clin.Infect.Dis. 28, 746–749 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Hoymans V.Y., Bosmans J.M., Van Rentherghem L., Mak R., Ursi D., Wuyts F., Vrints C.J., Ieven M.: Importance of methodology in determination ofChlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis.J.Clin.Microbiol. 41, 4049–4053 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Rajagopalan S.: Serious infections in elderly patients with diabetes mellitus.Clin.Infect.Dis. 40, 990–996 (2005).

    Article  PubMed  Google Scholar 

  • Schäffer P., Braun R.W., Mähring K., Henco K., Kang J., Wendland T., Kühn J.E.: Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophoresis.J.Gen.Virol. 74, 2699–2707 (1993).

    Article  Google Scholar 

  • Schummacher H.R., Lerkerod A.B., Seljeflot I., Sommervoll L., Holme I., Otterstad J.E., Arnesen H.:Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals.J.Clin.Microbiol. 39, 1859–1864 (2001).

    Article  Google Scholar 

  • Sodja I.: Serological survey of antibodies against chlamydiae.Zprvy CEM 7 (Suppl. 1), 34–36 (1998).

    Google Scholar 

  • Thomsen R.W., Hundborg H.H., Lervang H.H., Johnsen S.P., Schonheyder H.C., Sorensen H.T.: Diabetes mellitus as a risk factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults.Clin.Infect.Dis. 40, 628–631 (2005).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Roubalová.

Additional information

This project was supported by grant no. 1A8259-3/2004 of theInternal Grant Agency of the Ministry of Health of the Czech Republic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roubalová, K., Brož, J., Hrubá, D. et al. Prevalence of active infection withChlamydia pneumoniae and human cytomegalovirus in patients with type II diabetes mellitus. Folia Microbiol 52, 287–290 (2007). https://doi.org/10.1007/BF02931311

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02931311

Keywords

Navigation